These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9448886)

  • 1. Oral cyclophosphamide for refractory or relapsing thrombotic thrombocytopenic purpura (TTP).
    Hertzberg MS; Koutts J
    Aust N Z J Med; 1997 Aug; 27(4):439. PubMed ID: 9448886
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy.
    Allan DS; Kovacs MJ; Clark WF
    Haematologica; 2001 Aug; 86(8):844-50. PubMed ID: 11522541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
    Zheng X; Pallera AM; Goodnough LT; Sadler JE; Blinder MA
    Ann Intern Med; 2003 Jan; 138(2):105-8. PubMed ID: 12529092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising results from cyclophosphamide based immunosuppression therapy of thrombotic thrombocytopenic purpura.
    Guzicka-Kazimierczak R; Kazimierczak A; Clark J
    Pomeranian J Life Sci; 2015; 61(1):34-40. PubMed ID: 27116852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summaries for patients. Treatment of refractory thrombotic thrombocytopenic purpura.
    Ann Intern Med; 2003 Jan; 138(2):I38. PubMed ID: 12529111
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombotic thrombocytopenic purpura (TTP): initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases.
    Yang CW; Chen YC; Dunn P; Chang MY; Fang JT; Huang CC
    Ren Fail; 2003 Jan; 25(1):21-30. PubMed ID: 12617330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report.
    Yates S; Matevosyan K; Rutherford C; Shen YM; Sarode R
    Transfusion; 2014 Aug; 54(8):2064-7. PubMed ID: 24655327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of relapsing autoimmune thrombotic thrombocytopenic purpura with rituximab.
    Sankararaman S; Jeroudi M; Ibrahim H
    Pediatr Int; 2014 Dec; 56(6):914-918. PubMed ID: 25521977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic thrombocytopenic purpura treated with high-dose intravenous gamma globulin.
    Heyman MR; Sweet T
    South Med J; 1990 Dec; 83(12):1471-4. PubMed ID: 1701276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: report of two cases.
    Pérez-Sánchez I; Anguita J; Pintado T
    Ann Hematol; 1999 Jun; 78(6):285-7. PubMed ID: 10422632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus associated with thrombotic thrombocytopenic purpura: successful treatment with zidovudine.
    Salem G; Terebelo H; Raman S
    South Med J; 1991 Apr; 84(4):493-5. PubMed ID: 2014435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Response to rituximab in two patients with plasma exchange-refractory thrombotic thrombocytopenic purpura].
    Pérez A; Sancho JM; Grífols JR; Ribera JM
    Med Clin (Barc); 2011 Jun; 137(3):139-40. PubMed ID: 21074219
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombotic thrombocytopenic purpura, systemic lupus erythematosus and rescue treatment with cyclophosphamide].
    Ramírez Duque N; García Morillo JS; Andreu Alvarez J; Martino Galiana ML
    Rev Clin Esp; 2005 Oct; 205(10):520-2. PubMed ID: 16238970
    [No Abstract]   [Full Text] [Related]  

  • 14. Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab.
    Sukumar S; George JN; Cataland SR
    Am J Hematol; 2020 Apr; 95(4):E76-E77. PubMed ID: 31894592
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of relapsing thrombotic thrombocytopenic purpura with cyclophosphamide pulse therapy.
    Strutz F; Wieneke U; Braess J; Kaboth U; Kneba M; Rumpf KW; Grupp C; Müller GA
    Nephrol Dial Transplant; 1998 May; 13(5):1320-1. PubMed ID: 9623582
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus.
    Kamiya K; Kurasawa K; Arai S; Maezawa R; Hanaoka R; Kumano K; Fukuda T
    Mod Rheumatol; 2010 Feb; 20(1):81-5. PubMed ID: 19784542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura.
    Cataland SR; Jin M; Lin S; Kraut EH; George JN; Wu HM
    Am J Hematol; 2008 Dec; 83(12):911-5. PubMed ID: 18821711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura.
    Ahmad HN; Thomas-Dewing RR; Hunt BJ
    Eur J Haematol; 2007 May; 78(5):449-52. PubMed ID: 17331134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defibrotide in recurrent thrombotic thrombocytopenic purpura.
    Pogliani EM; Perseghin P; Parma M; Pioltelli P; Corneo G
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):69-70. PubMed ID: 10775024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cyclophosphamide benefit relapsing thrombotic thrombocytopenic purpura?
    Agarwal V; Sharma BL; Aggarwal A; Misra R
    J Assoc Physicians India; 2002 Nov; 50():1440-2. PubMed ID: 12583481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.